위식도역류질환의 치료에 관한 임상진료지침
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이준행 | - |
dc.contributor.author | 조유경 | - |
dc.contributor.author | 전성우 | - |
dc.contributor.author | 김지현 | - |
dc.contributor.author | 김나영 | - |
dc.contributor.author | 이준성 | - |
dc.contributor.author | 박영태 | - |
dc.contributor.author | 대한소화기기능성질환·운동학회 | - |
dc.date.accessioned | 2021-08-12T06:46:42Z | - |
dc.date.available | 2021-08-12T06:46:42Z | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 1598-9992 | - |
dc.identifier.issn | 2233-6869 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/17308 | - |
dc.description.abstract | Gastroesophageal reflux disease (GERD) is defined as a condition that develops when the reflux of stomach contents causes troublesome symptoms and/or complications. In the last decade, GERD has been increasing in Korea. Seventeen consensus statements for the treatment of GERD were developed using the modified Delphi approach. Acid suppression treatments,such as proton pump inhibitors (PPIs), histmine-2 receptor antagonists and antacids are effective in the control of GERD-related symptoms. Among them, PPIs are the most effective medication. Standard dose PPI is recommended as the initial treatment of erosive esophagitis (for 8 weeks) and non-erosive reflux disease (at least for 4 weeks). Long-term continuous PPI or on-demand therapy is required for the majority of GERD patients after the initial treatment. Anti-reflux surgery can be considered in well selected patients. Prokinetic agents and mucosal protective drugs have limited roles. Twice daily PPI therapy can be tried to control extra-esophageal symptoms of GERD. For symptomatic patients with Barrett's esophagus, long-term treatment with PPI is required. Further studies are strongly needed to develop better treatment strategies for Korean patients with GERD. | - |
dc.format.extent | 10 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한소화기학회 | - |
dc.title | 위식도역류질환의 치료에 관한 임상진료지침 | - |
dc.title.alternative | Guidelines for the Treatment of Gastroesophageal Reflux Disease | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.bibliographicCitation | 대한소화기학회지, v.57, no.2, pp 57 - 66 | - |
dc.citation.title | 대한소화기학회지 | - |
dc.citation.volume | 57 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 57 | - |
dc.citation.endPage | 66 | - |
dc.identifier.kciid | ART001530434 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Gastroesophageal reflux disease | - |
dc.subject.keywordAuthor | Treatment | - |
dc.subject.keywordAuthor | Guideline | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.